GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.66 $159.34 Thursday, 18th Apr 2024 ALNY stock ended at $145.16. This is 0.110% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.35% from a day low at $144.50 to a day high of $146.45.
90 days $143.52 $191.72
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2021-04-26 $137.78 $143.35 $135.97 $142.90 683 224
2021-04-23 $138.59 $140.47 $135.62 $136.72 327 950
2021-04-22 $136.45 $140.41 $134.67 $137.77 324 371
2021-04-21 $136.94 $138.48 $134.12 $137.53 236 264
2021-04-20 $131.75 $136.91 $131.75 $136.03 506 635
2021-04-19 $138.34 $140.82 $136.09 $137.40 492 633
2021-04-16 $139.59 $140.06 $137.39 $138.88 766 862
2021-04-15 $139.76 $142.71 $138.73 $139.02 428 329
2021-04-14 $137.40 $140.37 $136.18 $138.31 566 029
2021-04-13 $136.01 $137.00 $133.12 $136.23 477 023
2021-04-12 $137.08 $137.87 $134.09 $135.03 521 311
2021-04-09 $141.94 $142.31 $137.10 $138.23 419 212
2021-04-08 $143.21 $144.54 $141.10 $142.50 346 633
2021-04-07 $141.36 $143.04 $140.02 $140.67 336 517
2021-04-06 $141.15 $143.91 $141.02 $142.01 411 250
2021-04-05 $143.20 $144.93 $141.17 $142.65 399 239
2021-04-01 $143.17 $145.16 $140.49 $141.81 320 189
2021-03-31 $137.30 $142.28 $136.56 $141.19 539 672
2021-03-30 $132.66 $137.56 $130.53 $135.13 353 468
2021-03-29 $135.95 $136.73 $133.61 $133.80 319 816
2021-03-26 $134.48 $136.39 $133.02 $136.25 252 116
2021-03-25 $133.37 $135.74 $130.28 $135.24 637 321
2021-03-24 $139.33 $140.54 $134.01 $134.63 458 226
2021-03-23 $143.38 $143.64 $137.80 $138.66 400 392
2021-03-22 $143.57 $146.87 $140.70 $144.15 574 777
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT